36013004|t|SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide.
36013004|a|SU4312, initially designed as a multi-target tyrosine kinase inhibitor, is consequently reported to inhibit tumor angiogenesis by blocking VEGFR. However, although SU4312 can penetrate the brain-blood barrier, its potential to inhibit glioma growth is unknown. In this study, we report that SU4312 inhibited glioma cell proliferation and down-regulated yes-associated protein (YAP), the key effector of the hippo pathway. The exogenous over-expression of YAP partially restored the inhibitory effect of SU4312 on glioma progression. Interestingly, SU4312 sensitized the antitumor effect of temozolomide, both in vitro and in vivo. Moreover, SU4312 decreased the M2tumor-associated macrophages and enhanced anti-tumor immunity by down-regulating the YAP-CCL2 axis. In conclusion, our results suggest that SU4312 represses glioma progression by down-regulating YAP transcription and consequently CCL2 secretion. SU4312 may be synergistic with temozolomide for glioma treatment.
36013004	0	6	SU4312	Chemical	MESH:C549541
36013004	17	23	Glioma	Disease	MESH:D005910
36013004	50	53	YAP	Gene	10413
36013004	98	110	Temozolomide	Chemical	MESH:D000077204
36013004	112	118	SU4312	Chemical	MESH:C549541
36013004	157	172	tyrosine kinase	Gene	7294
36013004	220	225	tumor	Disease	MESH:D009369
36013004	251	256	VEGFR	Gene	3791
36013004	276	282	SU4312	Chemical	MESH:C549541
36013004	347	353	glioma	Disease	MESH:D005910
36013004	403	409	SU4312	Chemical	MESH:C549541
36013004	420	426	glioma	Disease	MESH:D005910
36013004	465	487	yes-associated protein	Gene	10413
36013004	489	492	YAP	Gene	10413
36013004	567	570	YAP	Gene	10413
36013004	615	621	SU4312	Chemical	MESH:C549541
36013004	625	631	glioma	Disease	MESH:D005910
36013004	660	666	SU4312	Chemical	MESH:C549541
36013004	702	714	temozolomide	Chemical	MESH:D000077204
36013004	753	759	SU4312	Chemical	MESH:C549541
36013004	823	828	tumor	Disease	MESH:D009369
36013004	861	864	YAP	Gene	10413
36013004	865	869	CCL2	Gene	6347
36013004	916	922	SU4312	Chemical	MESH:C549541
36013004	933	939	glioma	Disease	MESH:D005910
36013004	971	974	YAP	Gene	10413
36013004	1006	1010	CCL2	Gene	6347
36013004	1022	1028	SU4312	Chemical	MESH:C549541
36013004	1053	1065	temozolomide	Chemical	MESH:D000077204
36013004	1070	1076	glioma	Disease	MESH:D005910
36013004	Negative_Correlation	MESH:C549541	MESH:D005910
36013004	Negative_Correlation	MESH:C549541	10413
36013004	Negative_Correlation	MESH:C549541	7294
36013004	Association	10413	6347
36013004	Association	MESH:D005910	6347
36013004	Negative_Correlation	MESH:C549541	MESH:D009369
36013004	Association	MESH:D005910	10413
36013004	Negative_Correlation	MESH:C549541	6347
36013004	Cotreatment	MESH:C549541	MESH:D000077204
36013004	Negative_Correlation	MESH:C549541	3791
36013004	Negative_Correlation	MESH:D000077204	MESH:D005910

